## Diagnosis and Initial Management of Gestational Diabetes ### OGTT Interpretation **Key Point:** The 75 g OGTT diagnostic criteria (WHO 2013, adopted in India) are: - Fasting: ≥92 mg/dL - 1-hour: ≥180 mg/dL - 2-hour: ≥153 mg/dL This patient meets criteria at both 1-hour (182 mg/dL) and 2-hour (156 mg/dL) values, confirming gestational diabetes mellitus (GDM). ### First-Line Management **High-Yield:** The initial and preferred treatment for GDM is **medical nutrition therapy (MNT)** combined with structured self-monitoring of blood glucose (SMBG). Pharmacotherapy is reserved for those who fail dietary intervention. | Intervention | Timing | Target | Evidence | | --- | --- | --- | --- | | Medical nutrition therapy | Immediate | FBS <95 mg/dL, 2-h postprandial <120 mg/dL | First-line, reduces LGA and neonatal hypoglycemia | | Self-monitoring of blood glucose | Daily (4–6 times) | Fasting and 2-hour postprandial | Guides therapy escalation | | Pharmacotherapy (insulin/metformin) | After 2 weeks of failed MNT | If targets not met | Reserved for dietary failures | ### Why Not Insulin or Metformin Immediately? **Clinical Pearl:** Insulin is the gold standard for GDM pharmacotherapy (crosses placenta minimally), but metformin is increasingly used as first-line oral agent in resource-limited settings. However, **both are second-line** — MNT is always the first step. Immediate pharmacotherapy without trial of diet is not standard practice and increases unnecessary medication exposure. ### Repeat OGTT Consideration Once GDM is diagnosed on a single abnormal OGTT (meeting ≥1 threshold), the diagnosis is confirmed. Repeat testing is not needed for confirmation; it is used only if the first test is borderline or if clinical suspicion remains high despite a normal first test. **Mnemonic: GDM Management Ladder — DIET FIRST:** - **D**ietary counseling (carbohydrate counting, portion control) - **I**nsulin (if MNT fails after 2 weeks) - **E**xercise and self-monitoring - **T**arget glucose values (FBS <95, 2-h <120 mg/dL) --- ### Monitoring Schedule - Baseline: Fasting and postprandial glucose SMBG - 2 weeks: Assess adherence and glucose control - 28 weeks: Repeat OGTT if initial test was borderline (not applicable here) - Delivery: Close fetal and maternal monitoring - Postpartum: Glucose tolerance testing at 6 weeks (75 g OGTT or fasting glucose) **Key Point:** Approximately 15–20% of women with GDM will require pharmacotherapy after MNT failure.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.